Education
About Us
Working with TipRanks
Follow Us
Manzo Pharmaceuticals (MNZO)
OTHER OTC:MNZO
MNZO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.09 - $0.10
Previous CloseN/A
Volume590.00
Average Volume (3M)N/A
Market Cap
$1.10K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-84.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,099,522,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MNZO FAQ
What was Manzo Pharmaceuticals’s price range in the past 12 months?
Manzo Pharmaceuticals lowest stock price was $0.09 and its highest was $0.10 in the past 12 months.
What is Manzo Pharmaceuticals’s market cap?
Manzo Pharmaceuticals’s market cap is $1.10K.
When is Manzo Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Manzo Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Manzo Pharmaceuticals overvalued?
According to Wall Street analysts Manzo Pharmaceuticals’s price is currently Overvalued.
Does Manzo Pharmaceuticals pay dividends?
Manzo Pharmaceuticals does not currently pay dividends.
What is Manzo Pharmaceuticals’s EPS estimate?
Manzo Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Manzo Pharmaceuticals have?
Manzo Pharmaceuticals has 1,099,522,000 shares outstanding.
What happened to Manzo Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Manzo Pharmaceuticals?
Currently, no hedge funds are holding shares in MNZO
Company Description
Manzo Pharmaceuticals
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.